Insiders AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Market Closed - Nasdaq Other stock markets 01:30:00 28/06/2024 am IST			5-day change	1st Jan Change
5.93 ^USD	+2.95%		+0.17%	-24.36%

21/05	AngioDynamics Obtains CE Mark Approval in Europe for AlphaVac F18 System	MT
06/05	AngioDynamics, Inc. Announces Results from the Acute Pulmonary Embolism Extraction Trial with the Alphavac System (APEX-AV)	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Angiodynamics, Inc. Announces Board Changes	14/02	CI
AngioDynamics, Inc. Announces Dennis Meteny to Retire as A Member of the Board of Directors, Member of the Compensation Committee and Chair of the Audit Committee, Effective January 31, 2024	22/01	CI
David D. Helsel to Leave AngioDynamics, Inc. as Senior Vice President of Global Operations and R&D, Effective January 12, 2024	05/01	CI
AngioDynamics, Inc. Announces Addition of Lorinda Burgess to Board of Directors	25/23/25	CI
AngioDynamics, Inc. Announces Board Changes	27/23/27	CI
Insider Buy: Angiodynamics	12/22/12	MT
Insider Sell: Angiodynamics	02/22/02	MT
Insider Buy: AngioDynamics	13/22/13	MT
Insider Sell: Angiodynamics	19/21/19	MT
AngioDynamics, Inc. Announces Management Changes	01/21/01	CI
Insider Trends: AngioDynamics Insider Extends 90-Day Selling Trend	21/21/21	MT
Kevin Gould Intends to Retire from His Position as Director on the Board of Directors of AngioDyanmics	15/20/15	CI
AngioDynamics, Inc. Appoints Stephen Trowbridge as Executive Vice President and Chief Financial Officer	06/20/06	CI
AngioDynamics, Inc. Announces Management Changes	23/19/23	CI
AngioDynamics, Inc. Approves Appointment of Michael E. Tarnoff as Class I Director	18/19/18	CI
Jeffrey Gold Not to Stand for Reelection as Board of Directors of AngioDynamics, Inc	17/19/17	CI
AngioDynamics, Inc. Appoints Karen Licitra as a Class III Director and to Compensation Committee	20/19/20	CI
AngioDynamics, Inc. Announces Resignation of Robert A. Simpson as Senior Vice President and General Manager for Vascular Interventions and Therapies, Effective August 31, 2019	07/19/07	CI
AngioDynamics Inc. Announces Board Appointments	09/16/09	CI
Mark Stephens to Leave AngioDynamics Inc. as Senior Vice President, Administration, Effective September 23, 2016	09/16/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Insiders

Filters